Going-concern and liquidity pressure
The company disclosed substantial doubt about its ability to continue as a going concern if cash inflows disappoint.
- Scope
- Cash reserves and operating continuity
- Materiality
- high
TherapeuticsMD, Inc.
TherapeuticsMD, Inc. is a U.S.-based pharmaceutical royalty company focused on women’s healthcare products. Through licensing arrangements, it receives royalties tied to branded prescription products including IMVEXXY, BIJUVA, ANNOVERA, and prenatal vitamin brands sold in the United States and its territories.
−132,6 %
−18,8 %
+71,6 %
3.02
3.02
| % | |
|---|---|
| Prescription women’s health royalties | 85% Royalty streams tied to licensed prescription products for menopause, contraception, and prenatal care. |
| Prenatal vitamin brands | 15% Royalties from prescription prenatal vitamin products sold under BocaGreenMD and vitaMedMD. |
TherapeuticsMD’s direct commercial counterparties are pharmaceutical licensees and distributors that market its...
- Licensee pharmaceutical partnersprimary
Mayne Pharma and other commercial partners pay royalties and market the licensed products.
- Menopause therapy patientsprimary
Patients using IMVEXXY and BIJUVA for menopause-related symptoms drive royalty-bearing sales.
- Contraception patientssecondary
Users of ANNOVERA generate prescription volume for the licensed contraceptive product.
- Prenatal supplement userssecondary
Patients and prescribers using BocaGreenMD and vitaMedMD prenatal vitamins support royalty income.
The company’s royalty portfolio is concentrated in the United States and its possessions and territories, where the...
- •Revenue is concentrated in the United States and its territories
- •Licensed products are commercialized under U.S. rights only
- •Geographic exposure is tied to U.S. prescription and payer dynamics
- •No meaningful direct international operating footprint is disclosed
- •Royalty model reduces physical manufacturing geography exposure
TherapeuticsMD’s strategy is to monetize its women’s healthcare portfolio through royalty and license agreements rather...
01
Maximize royalty collection from licensed productsshort-term
Royalty income is the company’s core operating model and main source of revenue.
02
Defend and enforce contractual economicsshort-term
Disputes over rebates, returns, and working capital can change cash receipts and reported revenue.
03
Maintain value of licensed women’s health brandsmedium-term
The royalty stream depends on continued market demand for the underlying products.
TherapeuticsMD faces concentrated counterparty risk because most of its economics depend on a small number of license...
Mayne Pharma contractual disputes
Allowance calculations, returns, rebates, and working-capital true-ups can alter revenue and cash collections.
- Scope
- Royalty receivables and license revenue
- Materiality
- high
Concentration in a few licensed products
A small portfolio means sales declines in one product can materially affect total royalties.
- Scope
- IMVEXXY, BIJUVA, ANNOVERA, prenatal brands
- Materiality
- high
Licensee execution risk
TherapeuticsMD relies on third parties for commercialization, supply chain, and market access.
- Scope
- Mayne Pharma commercialization and contract manufacturers
- Materiality
- medium
Royalty revenue recognition
Affects reported license revenue and receivables
Allowance estimates for rebates, returns, and distributor fees
Affects net revenue and working-capital settlements
Royalty receivable collectability
Affects balance sheet valuation and liquidity assessment
Impairment and write-offs
Affects operating expenses and asset values
Turn Therapeutics Inc.
TTRX · Pharmaceutical Preparations
UNITED THERAPEUTICS Corp
UTHR · Pharmaceutical Preparations
United Therapeutics is a U.S.-based biopharmaceutical company focused on therapies for pulmonary arterial hypertension and other serious rare diseases, along with organ manufacturing technologies.
Context Therapeutics Inc.
CNTX · Pharmaceutical Preparations
TG THERAPEUTICS, INC.
TGTX · Pharmaceutical Preparations
TG Therapeutics is a U.S.-based biopharmaceutical company focused on developing and commercializing treatments for B-cell diseases and related immune-mediated disorders.
Transcode Therapeutics, Inc.
RNAZ · Pharmaceutical Preparations
Metagenomi Therapeutics, Inc.
MGX · Biological Products, (No Diagnostic Substances)
: 29/04/2026